In addition JAK inhibitor AG490 showed the same effect as knockdown of CXCL6 and it is likely that CXCL6 may promote fibrosis-related factors to accelerate the development of DN renal interstitial fibrosis by activating JAK/STAT3 signaling pathway. The gene discussed is CXCL6; the disease is liver dysplastic nodule.